TY  - GEN
AU  - Liby,Karen
AU  - Rendi,Mara
AU  - Suh,Nanjoo
AU  - Royce,Darlene B
AU  - Risingsong,Renee
AU  - Williams,Charlotte R
AU  - Lamph,William
AU  - Labrie,Fernand
AU  - Krajewski,Stan
AU  - Xu,Xiaochun
AU  - Kim,Heetae
AU  - Brown,Powel
AU  - Sporn,Michael B
TI  - The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancer
SN  - 1078-0432
PY  - 2006///1109
KW  - Animals
KW  - Cell Division
KW  - drug effects
KW  - Disease Models, Animal
KW  - Drug Synergism
KW  - Drug Therapy, Combination
KW  - Female
KW  - Humans
KW  - Mammary Neoplasms, Experimental
KW  - drug therapy
KW  - Mice
KW  - Mice, Transgenic
KW  - Nicotinic Acids
KW  - therapeutic use
KW  - Piperidines
KW  - Receptors, Estrogen
KW  - metabolism
KW  - Selective Estrogen Receptor Modulators
KW  - pharmacology
KW  - Survival Rate
KW  - Tetrahydronaphthalenes
KW  - Thiophenes
N1  - Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1158/1078-0432.CCR-06-1119
ER  -